From Nigeria to Senegal and everywhere in between, West Africa is home to a rich culinary culture that transcends national ...

The Omanhene of the Banda Traditional Council, Nana Sekyemme Sinapem II, has commended the New Patriotic Party (NPP) for ...

Cassava faces a cash burn of $80-$90 million in the second half of 2024, which will significantly reduce its current cash runway. Due to data integrity issues and unproven efficacy, I maintain a ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Alzheimer’s drug developer Cassava Sciences agreed Thursday to pay $40 million to settle regulatory claims that it misled investors about the results of a clinical trial that showed promise for ...

The research behind Cassava Sciences’ Alzheimer’s drug candidate, simufilam, and the idea of targeting a brain protein called filamin, is based on a series of papers from a group at CUNY and ...

Market is estimated to be valued at USD 1.88 Bn in 2024 and is expected to reach USD 3.78 Bn by 2031, exhibiting a compound ...

Cassava Sciences has agreed to pay $40 million to resolve an investigation into claims it made misleading statements about phase 2b data on its Alzheimer’s disease drug candidate. The U.S ...

Cassava Sciences faced a $40 million penalty to focus on Simufilam's development following SEC charges over misleading trial data. Cassava Sciences completed ReTHINK Phase 3 trial with 804 ...

WASHINGTON, Sept 26 (Reuters) - Shares of Cassava Sciences (SAVA.O), opens new tab fell 10% in post-market trading on Thursday after the U.S. Securities and Exchange Commission charged the ...

A new five-year scheme called Rwanda Agricultural Biotechnology Program (Cassava, Maize, Potato - CMP), is expected to contribute to improvement in crop productivity, according to its developers. The ...